Manufacturer record
Alves Healthcare Private Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
13 batches manufactured by Alves Healthcare Private Limited (Himachal Pradesh) were declared Not of Standard Quality between August 2019 and August 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
13 records linked to Alves Healthcare Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Adrenaline Injection I.P. Sterile 1 ml | AI22268Mfg 2022-09 · Exp 2024-08 | Description, Appearance of Solution, Particulate Matter & AssayAssay | CDL KolkataCDSCO lab | Aug 2024 |
| Diclofenac Sodium Tablets IP 50 mg | AT22201Mfg 2022-08 · Exp 2024-07 | Disintegratio nOther | CDL KolkataCDSCO lab | Sep 2023 |
| Frusemide Injection IP (2ml) | AI22236Mfg 2022-08 · Exp 2024-07 | pHpH | CDL KolkataCDSCO lab | Aug 2023 |
| Erythromycin Stearate Tablets IP 250 mg | AT23118Mfg 2023-04 · Exp 2025-03 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2023 |
| Rabeprazole Gastro-Resistant Tablets IP 20 mg | AT23029Mfg 2023-02 · Exp 2025-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2023 |
| Erythromycin Stearate Tablets IP 250 mg | AT22356Mfg 2022-12 · Exp 2024-11 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
| Doxycycline Capsules IP | AC22031Mfg 2022-10 · Exp 2024-09 | AssayAssay | CDL KolkataCDSCO lab | May 2023 |
| RANTIDINE HYDROCHLORIDE TABLETS IP 150 mg | AT22200Mfg 2022-08 · Exp 2024-07 | Uniformity of WeightUniformity of weight/content | CDTL HyderabadCDSCO lab | Apr 2023 |
| ALGLIMET M1 (Glimepiride 1 mg & Metformin 500 mg Tablets SR) | AT22068Mfg 2022-03 · Exp 2024-02 | Assay and Dissolution of GlimepirideAssay | CDTL KolkataCDSCO lab | Mar 2023 |
| Iron & Folic Acid Syrup IP, 50 ml. | AHL21015Mfg 2021-05 · Exp 2023-04 | ?pH? and Identification & Assay of ?Folic Acid?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Iron & Folic Acid Syrup IP, 50 ml | AHL21034Mfg 2021-05 · Exp 2023-04 | ?pH? and ?Identification & Assay of Folic Acid?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Iron & Folic Acid Syrup IP (50 ml) | AHL21012Mfg 2021-05 · Exp 2023-04 | ?pH?, Identification & Assay of ?Folic Acid?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Frusemide Injection I.P. 2 ml | AI18064Mfg 2018-07 · Exp 2020-06 | Extractable VolumeExtractable volume | CDL KolkataCDSCO lab | Aug 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.